Omni is first company in Guyana to receive ‘Great Place To Work®’ certification

Must Read

OilNOW
OilNOW
OilNOW is an online-based Information and Resource Centre

Omni Helicopters International said its operations in Guyana, through Omni Helicopters Guyana Inc (OHGI), have been Certified™ by San Francisco firm Great Place To Work®. 

Great Place to Work Certification is a benchmark for recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply for Great Place To Work certification. The organization certifies companies that meet its criteria and recognizes them through various lists. 

Omni said this is a significant milestone for Guyana as it is the first company in the country to receive this recognition.

The survey was a group-wide initiative designed to gain insights into employees’ perceptions of the organization, Omni said. Specifically, the survey targeted Omni Táxi Aéreo and Revo in Brazil, OHI in Portugal, and OHGI in Guyana with all surveyed organizations successfully attaining the certification. 

“Great Place To Work Certification is a highly coveted achievement that requires consistent dedication to the overall employee experience,” says Sarah Lewis-Kulin, the Vice President of Global Recognition at Great Place To Work.

Six Guyanese selected for aviation security roles with Omni Helicopters | OilNOW

Peter Gay, Country Manager for Omni Helicopter Guyana Inc. said, “Our commitment to deliver exceptional customer service can only be achieved through our employees and this type of certification, which benchmarks against the best in the world, is essential to ensure that we are best-in-class and can ensure a positive and consistent employee experience.” 

Omni Helicopters transports passengers in support of ExxonMobil’s Guyana operations. It celebrated one year of existence in Guyana in January, noting that it conducted 2,300 flights with more than 50,000 passengers. 

- ADVERTISEMENT -
spot_img

Partnered Events

Latest News

Sensorion Announces New Positive Secondary Efficacy Endpoints Data From SENS-401 Phase 2a Clinical Trial For The Preservation Of Residual Hearing Loss

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel...

More Articles Like This